Patents by Inventor Andrew John Briggs

Andrew John Briggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-piperazinylindole derivatives with 5-HT6 receptor affinity
    Patent number: 6790848
    Abstract: This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula I: wherein R3 is SO2—Ar, Ar is aryl or heteroaryl; and R1, R2, R4 and R5 are as defined herein; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: September 14, 2004
    Assignee: Syntex (U.S.A.) LLC
    Inventors: Andrew John Briggs, Robin Douglas Clark, Ralph New Harris, III, David Bruce Repke, Douglas Leslie Wren
  • 4-piperazinylindole derivatives with 5-HT6 receptor affinity
    Publication number: 20030045527
    Abstract: This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula I: 1
    Type: Application
    Filed: June 14, 2002
    Publication date: March 6, 2003
    Inventors: Andrew John Briggs, Robin Douglas Clark, Ralph New Harris, David Bruce Repke, Douglas Leslie Wren